期刊文献+

人Midkine启动子驱动的HSV-TK自杀基因体外抗肝癌作用 被引量:3

Effect of adenovirus-mediated transfer of HSV-tk/GCV drived by human midkine promoter on human hepato cellular carcinoma in vitro
下载PDF
导出
摘要 目的观察以人Midkine(MK)启动子调控单纯疱疹病毒胸苷激酶基因(HSV-TK)/丙氧鸟苷(GCV)自杀基因系统在体外对人肝癌细胞的杀伤效应。方法以含有人MK启动子调控的HSV-TK基因的重组腺病毒分别感染体外培养的甲胎蛋白(AFP)阳性人肝癌细胞BEL-7402和AFP阴性人肝癌细胞SMMC-7721,RT-PCR法检测HSV-TK基因在上述两种细胞中的转录表达,观察GCV对人肝癌细胞的杀伤作用。结果GCV在体外对重组腺病毒感染的BEL-7402及SMMC-7721均有明显的杀伤作用,又以前者为著。相同的病毒滴度,其杀伤作用随着GCV浓度的增高而增强。均具有旁观者效应。结论在体外表现HSV-TK基因的AFP阳性及阴性人肝癌细胞均可被人MK启动子调控的自杀基因HSV-TK杀伤。 Objective To observe and examine the killing effect of the herpes simplex virus thymidine kinase/ganciclovir (HSV-TIC/GCV) suicide gene system transferred by adenovirus on human HCC in vitro. Methods The AFP- positive human HCC cell line BEL-7402 and AFP-negative human HCC cell line SMMC-7721 were infected with the recombinant adenoviral vector containing HSV-TK gene derived by human midkine promoter. The intracellular transcription of this recombinant was detected by RT-PCR, and the effect of GCV on killing the human HCC cells was observed using microscope and MTT. Results In vitro, GCV exerts remarkable killing effect and the "bystander effect" on AFP-positive BEL-7402 as well as AFP-negative cells SMMC-7721. The killing effect was enhanced following to the GCV concentration preconditioned with same recombinant adenovirus. Conclusion Both of AFP-positive and AFP-negative human HCC cells with HSV-tk gene expressing can be killed by suicide gene HSV-TK which is controlled by human midkine promoter.
出处 《山东医药》 CAS 北大核心 2009年第20期29-32,共4页 Shandong Medical Journal
关键词 MIDKINE 启动子 单纯疱疹病毒胸苷激酶基因 丙氧鸟苷 肝肿瘤 Midkine promoter herpes simplex virus thymidine kinase gancclovir hepatocellular carcinoma
  • 相关文献

参考文献9

  • 1Tomizawa M,Yu L,Wada A,et al.A promoter region of the midkine gene that is frequently expressed in human HCC can activate a suicide gene as effectively as the alpha-fetoprotein promoter[J].Br J Cancer,2003,89(6):1086-1090.
  • 2Shalev M,Miles BJ,Thompson TC,et al.Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene[J].World J Urol,2000,18(2):125-129.
  • 3Vassaux G,Martin-Duque P.Use of suicide genes for cancer gene therapy:study of the different approaches[J].Expert Opin Biol Ther,2004,4(4):519-530.
  • 4Vassaux G,Martin-Duque P.Use of suicide genes for cancer gene therapy:study of the different approaches[J].Expert Opin Biol Ther,2004,4(4):519-530.
  • 5Niculescu-Duvaz I,Springer CJ.Introduction to the background,principles,and state of the art in suicide gene therapy[J].Mol Biotechnol,2005,30(1):71-88.
  • 6Hall EJ.The bystander effect[J].Health Phys,2003,85(1):31-35.
  • 7Brooks AL.Evidence for 'bystander effects' in vivo[J].Hum Exp Toxicol,2004,23(2):67-70.
  • 8Jiang JX,Gu S.Gap junction-and hemichannel-independent actions of connexins[J].Biochim Biophys Acta,2005,1711(2):208-214.
  • 9陈道桢.自杀基因治疗中的旁观者效应及机制[J].国外医学(遗传学分册),2002,25(4):199-201. 被引量:5

二级参考文献17

  • 1Dilber MSetal. Cancer Res,1997,57:1523-1528.
  • 2Ishii-Morit AHet al. Gene Ther.1997.4:244-251.
  • 3Mesnil M et al. Proc Natl Acad Sci USA, 1996, 93: 1831-1835.
  • 4Pitts JD. Mol Carcinogenesis,1994,11:127-130.
  • 5Carystinos GD et al. Clin Cancer Res.1996.1:61-68.
  • 6Andrade AF et al. Brain Res,2000.32(1):308-312.
  • 7Wygoda MR et al. Cancer Res.1997,57(9):1699-1703.
  • 8Samejima Y et al. Gene Ther.1995.2:50-58.
  • 9Freeman SM et al. Cancer Res,1993,53(21) :5274-5283.
  • 10Consavol Metal. J Immunol,1995,154:5302-5306.

共引文献4

同被引文献43

  • 1夏曦,王蓓蓓,陈刚,吴鹏,罗丹枫,李辅军,郉辉,王金韬,卢运萍,周剑锋,马丁.环孢素A延长腺病毒基因治疗载体体内存在时间的研究[J].医学分子生物学杂志,2006,3(3):186-189. 被引量:1
  • 2李宝金,张超,伊远学,郝颖,刘晓平,区庆嘉.Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer Driver by KDR Promoter in Treatment of Experimental Human HepatocelLular Carcinoma in Nude Mice[J].Chinese Journal of Cancer Research,2007,19(1):22-26. 被引量:1
  • 3Avila MA, Berasain C, Sangro B, et al.New therapies for hepato- cellular carcinoma[ J]. Oncogene,2006,25 (27) :3866-3884.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 5de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis[J].Lancet Oncol,2012,13 (6) :607-615.
  • 6Livraghi T, Makisalo H, Line PD. Treatment options in hepatocel- lular carcinoma today[ J]. Scand J Surg,2011,100( 1 ) :22-29.
  • 7Ek-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treat- ment of hepatocellular carcinoma[ J ]. Gastroenterology,2008,134 (6) :1752-1763.
  • 8Schepelmann S, Springer CJ. Viral vectors for gene-directed en- zyme prodmg therapy [ J ]. Curr Gene Thor,2006,6 (6) :647-670.
  • 9Nasu Y, Saika T, Ebara S, et al. Suicide gene therapy with ade- noviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy[ J]. Mol Ther,2007,15 (4) :834-840.
  • 10Chevez-Barrios p, Chintagumpala M, Mieler W, et al. Response of retinoblastoma with vitreous tumor seeding to adenovirus-media- ted delivery of thymidine kinase followed by ganciclovir[ J]. J Clin Oncol, 2005,23 ( 31 ) : 7927- 7935.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部